Inspire Medical Systems, Inc. INSP 深 沪
等待开盘 11-10 09:30:00 美东时间
64.33
+0.350
+0.55%
华盛通- 最 高64.735
- 今 开64.01
- 成交量 52.16万股
- 最 低 62.93
- 昨 收 63.98
- 总市值 18.63亿
- 52周最高 147.03
- 市盈率 静 13.16
- 换手率 1.80%
- 52周最低 38.91
- 委 比 -33.33%
- 总股本 2896.61万
- 历史最高 330.00
- 量 比 0.52
- 振 幅 2.82%
- 历史最低 22.50
- 每 手 1
- 风险率 22.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 苹果、雅诗兰黛、莱迪思半导体均获大行上调目标价
今日重点评级关注：Rosenblatt：维持SiTime"买入"评级，目标价从750美元升至900美元；花旗：维持Madrigal Pharmaceuticals"买入"评级，目标价从725美元升至760美元
11-04 18:17
These Analysts Increase Their Forecasts On Inspire Medical After Strong Q3 Results
Inspire Medical Systems, Inc. (NYSE:INSP) reported upbeat earnings for the third quarter on Monday. The company posted quarterly earnings of 14 cents per share which beat the analyst consensus estimate of 9 cents per share. The company reported quarterly sales of $206.695 million which beat the anal...
11-03 21:09
Baird Maintains Neutral on Inspire Medical Systems, Raises Price Target to $77
Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $73 to $77.
11-03 19:41
财报速睇 | Inspire Medical Systems, Inc. 2026财年Q3营收2.07亿美元，同比下降7.9%；归母净利润亏损0.24亿美元，由盈转亏
华盛资讯11月3日讯，Inspire Medical Systems, Inc.公布2026财年Q3业绩，公司Q3营收2.07亿美元，同比下降7.9%，归母净利润亏损0.24亿美元，由盈转亏。
11-03 06:34
财报速睇 | Inspire Medical Systems, Inc. 2026财年Q3营收2.07亿美元，同比下降7.9%；归母净利润亏损0.24亿美元，由盈转亏
华盛资讯11月3日讯，Inspire Medical Systems, Inc.公布2026财年Q3业绩，公司Q3营收2.07亿美元，同比下降7.9%，归母净利润亏损0.24亿美元，由盈转亏。
11-03 05:52
Inspire Medical Systems Q3 Adj. EPS $0.14 Beats $0.09 Estimate, Sales $206.695M Beat $204.304M Estimate
Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.09 by 55.56 percent. This is a 63.16 percent decrease over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $206.695 m...
11-03 05:46
美股大行评级 | 潜在涨幅325.53%！HC Wainwright维持Alector"买入"评级，目标价上调至8美元
今日重点评级关注：HC Wainwright & Co.：维持Alector"买入"评级，目标价从5美元升至8美元；摩根大通：维持ORIC Pharmaceuticals"超配"评级，目标价从23美元升至26美元
10-15 12:36
Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78
Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $62 to $78.
10-15 01:31
美股大行评级 | 潜在涨幅1654.39%！Ascendiant Capital上调NRX Pharmaceuticals(NRXP)目标价至50美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从49美元升至50美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从24美元升至25美元
10-02 08:33
RBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75
RBC Capital analyst Kendall Au maintains Inspire Medical Systems (NYSE:INSP) with a Sector Perform and raises the price target from $60 to $75.
10-01 21:08
